BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medicine by Design - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://mbd.ccrm.ca
X-WR-CALDESC:Events for Medicine by Design
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210316T120000
DTEND;TZID=America/Toronto:20210316T130000
DTSTAMP:20260405T205446
CREATED:20210211T171832Z
LAST-MODIFIED:20210216T201224Z
UID:12647-1615896000-1615899600@mbd.ccrm.ca
SUMMARY:Global Speaker Series: Magdalena Götz\, PhD - University of Munich and Helmholtz Center Munich
DESCRIPTION:The Medicine by Design Global Speaker Series invites established and emerging international leaders in regenerative medicine to engage with our extraordinary community of researchers and clinicians. \nMedicine by Design\, in partnership with the McEwen Stem Cell Institute\, is pleased to welcome Magdalena Götz\, PhD\, professor at the Biomedical Center\, University of Munich and Institute for Stem Cell Research\, Helmholtz Center Munich\, Germany. \nThe title of this talk will be\, “Novel mechanisms of neurogenesis and neural repair” \n Register for this virtual event. \n \nMore About Magdalena Götz: \nProfessor Götz’s lab studies the mechanisms of neurogenesis in order to implement them for neuronal repair. She will present recent work on a novel centrosomal protein\, Akna\, regulated with great precision in subsets of neural stem cells. This led Professor Götz’s lab to unravel an unprecedented centrosome heterogeneity in human neural stem cells revealing and verifying novel disease candidates. She will proceed to present recent data on a master regulator of nuclear compartmentalization by liquid phase transition with key roles in promoting neural stem cell self-renewal and neurogenesis. Trnp1 is also critical for direct neuronal reprogramming which leads to discuss recent progress in direct neuronal reprogramming as a means to replace lost neurons after brain injury. The presentation will be concluded by discussing the integration of replaced neurons into the circuitry of the murine cerebral cortex and present unpublished data about the mechanisms regulating this integration. Taken together\, our knowledge about basic mechanisms of neurogenesis allowed making great strides towards neuronal repair. \n Learn more about Magdalena Götz’s lab
URL:https://mbd.ccrm.ca/event/global-speaker-series-magdalena-gotz-phd-university-of-munich-and-helmholtz-center-munich/
LOCATION:Virtual
CATEGORIES:Global Speaker Series
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210302T100000
DTEND;TZID=America/Toronto:20210302T120000
DTSTAMP:20260405T205446
CREATED:20210111T190722Z
LAST-MODIFIED:20210429T142434Z
UID:12004-1614679200-1614686400@mbd.ccrm.ca
SUMMARY:Building a Biotech Venture
DESCRIPTION:  \nNext session: March 2\, 10 a.m. to 12 p.m. – 10 Point Plan Workshop\n\nRegistration Now Closed – Email info.mbd@utoronto.ca if you have any questions. \nLooking to translate your regenerative medicine research or technology into a product or venture but don’t know where to start? \nTake your first steps toward entrepreneurship with Building a Biotech Venture\, a new program for regenerative medicine-focused trainees in labs at the University of Toronto or its affiliated hospitals\, offered in partnership with the Health Innovation Hub (H2i)\, a campus-linked accelerator at the Temerty Faculty of Medicine at U of T. \nThrough a series of workshops over winter/spring 2021\, you will: \n\nlearn how to think about your research in terms of a product or business;\nconnect with peers to form a venture team;\ndevelop your product or venture “story”;\nbuild a business canvas and pitch deck; and\nreceive mentoring and guidance from industry experts throughout the process.\n\nThe program will culminate in a pitch competition in spring 2021 where the winning team will receive up to $25\,000 in research funding to advance their product or venture concept. \nThis is a virtual event \n\nBuilding a Biotech Venture program breakdown:\n\n\nSession 1: Information Session – **Note: Live session has passed but you can still participate in the program provided you have registered by Feb. 23. \nWatch recording here\, or you can review the FAQ.\nJan. 26\, 11 a.m. to 12 p.m.\nThis session will provide an overview of the program and how to enroll\, as well as an introduction to H2i’s 10-point plan\, which outlines 10 key elements of a business canvas. Medicine by Design will help facilitate venture team creation between session 1 and session 2 for those who do not have an existing team.\nSession 2: H2i’s 10-Point Plan Workshop\nRegistration Now Closed – Email info.mbd@utoronto.ca if you have any questions.\nMarch 2\, 10 a.m. to 12 p.m.\nTeams will dive into more detail on H2i’s 10-point plan\, and start developing a venture one-pager and a pitch deck on their venture concept. Mentors from H2i’s community will work with teams during the workshop to provide feedback. Post-workshop\, teams will be assigned H2i mentors and receive ongoing mentoring to further develop their business cases and pitch decks.\nSession 3: Medicine by Design Pitch Competition\nSpring 2021\nTeams who attended the session 2 workshop are invited to apply to this pitch competition. The winning team will receive up to $25\,000 in research funding to advance their product concept.\n\nIf you have any immediate questions regarding this program\, please contact Stephanie Hume (stephanie.hume@utoronto.ca).
URL:https://mbd.ccrm.ca/event/building-a-biotech-venture/
CATEGORIES:Partner Events,Workshops
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210216T120000
DTEND;TZID=America/Toronto:20210216T130000
DTSTAMP:20260405T205446
CREATED:20201222T071349Z
LAST-MODIFIED:20210202T165247Z
UID:11577-1613476800-1613480400@mbd.ccrm.ca
SUMMARY:Global Speaker Series: Manu Platt\, PhD - Georgia Institute of Technology\, and Emory University
DESCRIPTION:The Medicine by Design Global Speaker Series invites established and emerging international leaders in regenerative medicine to engage with our extraordinary community of researchers and clinicians. \nMedicine by Design\, in partnership with the McEwen Stem Cell Institute\, is pleased to welcome Manu Platt\, PhD\, associate professor at the Wallace H. Coulter Department of Biomedical Engineering at the Georgia Institute of Technology\, and Emory University. \nThe title of this talk will be\, “Things Fall Apart: Proteolytic Networks in Tissue Destructive Diseases” \n Register for this virtual event \n \nMore About Manu Platt:\nManu Platt received his BS in biology from Morehouse College in 2001 and his PhD from the Georgia Tech and Emory joint program in biomedical engineering in 2006. He finished his post–doctoral training at MIT in orthopedic tissue engineering and systems biology prior to returning to Georgia Tech and Emory’s Joint Department of Biomedical Engineering in 2009\, where he has since been promoted and tenured. His research centres on proteolytic mechanisms of tissue remodeling during disease progression using both experimental and computational approaches. \nIntegrated with his research program is his mentoring goal of changing the look of the next generation of scientists and engineers to include all colours\, genders\, and backgrounds. Aligned with that goal\, Dr. Platt\, along with Bob Nerem\, co-founded and co-directs Project ENGAGES (Engaging the Next Generation At Georgia Tech in Engineering and Science)\, a program paying African-American high school students from Atlanta Public Schools to be researchers in Georgia Tech labs since 2013.
URL:https://mbd.ccrm.ca/event/global-speaker-series-manu-platt-phd-georgia-institute-of-technology-and-emory-university/
CATEGORIES:Global Speaker Series
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210210T110000
DTEND;TZID=America/Toronto:20210210T120000
DTSTAMP:20260405T205446
CREATED:20210201T142350Z
LAST-MODIFIED:20210429T141611Z
UID:12330-1612954800-1612958400@mbd.ccrm.ca
SUMMARY:Conversations in Convergence: Yun Li\, PhD\, and Erica Scott\, PhD
DESCRIPTION:Join us for our first edition of Conversations in Convergence\, a series of interactive discussions between Medicine by Design researchers who study similar questions using different approaches. \nOur first speakers will be: \n\nYun Li\, PhD – Scientist\, Developmental & Stem Cell Biology\, The Hospital for Sick Children; Assistant Professor\, Department of Molecular Genetics\, University of Toronto; and Medicine by Design Investigator \nErica Scott\, PhD – Post-Doctoral Fellow\, Wheeler Microfluidics Lab\, Department of Chemistry and Institute of Biomaterials & Biomedical Engineering\, University of Toronto; and 2018 Medicine by Design Post-Doctoral Fellowship award winner  \n\n \nDr. Li studies how the human brain is formed\, what makes the human brain different from that of the other species\, and how disorders such as autism impact its normal development and function. She uses pluripotent stem cell\, genome editing\, and 3-dimensional organoid technologies to study brain development in a dish.  \nIn Dr. Scott’s post-doctoral fellowship\, she is developing a tool to analyze neural stem cell networks at single-cell resolution. This tool combines a single cell laser lysis technique\, microfluidics and RNA and DNA sequencing. Dr. Scott aims to describe the high degree of variability between neural stem cells and their environment to best harness their therapeutic potential.  \n\nThe goal of Conversations in Convergence is to foster cross-disciplinary discussions in support of convergence\, which is the integration of approaches from engineering\, science\, medicine and other fields to expand knowledge and spark innovation. The researchers will discuss how their unique perspectives\, knowledge and ideas inform their work\, and how their diverse approaches intersect and complement one another to advance regenerative medicine.  \nRegister now\n 
URL:https://mbd.ccrm.ca/event/conversations-in-convergence-february-2020/
CATEGORIES:Other Events
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210203T150000
DTEND;TZID=America/Toronto:20210203T163000
DTSTAMP:20260405T205446
CREATED:20210120T214054Z
LAST-MODIFIED:20210121T000410Z
UID:12153-1612364400-1612369800@mbd.ccrm.ca
SUMMARY:Cycle 2 Discussion Group: Applying single-cell RNA sequencing technologies to your research
DESCRIPTION:Medicine by Design is launching a new discussion group series to provide an opportunity for investigators and trainees from Cycle 2 projects to connect with each other\, discuss overlapping interests\, and share information about the development and implementation of new technologies and tools that could be applicable to multiple projects. Each session will feature two speakers from Cycle 2 projects\, followed by a group discussion. \n  \nRegister now\n  \n\nChair\n\nDr. Michael Laflamme\nSenior Scientist\, McEwen Stem Cell Institute\, and Staff Pathologist\,\nUniversity Health Network\n \n \nCycle 2 Project Lead:\n“Cardiac regeneration using pluripotent stem cells” \nSpeakers\nDr. Slava Epelman\nScientist\, Toronto General Hospital Research Institute and Staff Cardiologist\,\nPeter Munk Cardiac Centre\, UHN \n \nCycle 2 projects:\n“Cardiac regeneration using pluripotent stem cells” (Lead PI: Michael Laflamme)\n“Investigating how age-related clonal hematopoiesis drives HSC stemness properties and how this leads to inflammatory diseases of the heart” (Lead PI: John Dick) \nProfessor Gary Bader\nDonnelly Centre for Cellular and Biomolecular Research and the\nDepartment of Molecular Genetics\, University of Toronto\n \n \nCycle 2 Projects:\n“Stem cell- based approaches to endogenous repair of the brain and skeletal muscle” (Lead PI: Freda Miller)\n“Development of novel cell and tissue therapies to treat liver failure” (Lead PI: Gordon Keller) \n“Investigating how age-related clonal hematopoiesis drives HSC stemness properties and how this leads to inflammatory diseases of the heart” (Lead PI: John Dick) \n\nAbout Cycle 2 Thematic Discussion Groups\nThemes will focus on a technology or platform that is applicable across multiple Cycle 2 projects (e.g. single-cell sequencing\, imaging\, synthetic biology) or cross-cutting scientific themes (e.g. inflammation). The discussion groups will be held bi-monthly. \nEach meeting will be chaired by one of our Cycle 2 principal investigators. If you or an investigator on your team are interested in chairing an upcoming session\, or have a topic you would like to see discussed\, please reach out to Stephanie Hume (stephanie.hume@utoronto.ca).
URL:https://mbd.ccrm.ca/event/cycle-2-thematic-discussion-group-applying-single-cell-rna-sequencing-technologies-to-your-research/
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210119T120000
DTEND;TZID=America/Toronto:20210119T130000
DTSTAMP:20260405T205446
CREATED:20201221T222251Z
LAST-MODIFIED:20210113T203542Z
UID:11573-1611057600-1611061200@mbd.ccrm.ca
SUMMARY:Global Speaker Series: Allon Klein\, PhD - Harvard University
DESCRIPTION:The Medicine by Design Global Speaker Series invites established and emerging international leaders in regenerative medicine to engage with our extraordinary community of researchers and clinicians. \nMedicine by Design\, in partnership with the McEwen Stem Cell Institute\, is pleased to welcome Allon Klein\, PhD\, an Associate Professor of Systems Biology at Harvard Medical School. \nThe title of this talk will be\, “Lineage tracing on transcriptional landscapes” \n Register for this virtual event. \n  \n \nMore About Allon Klein: \nProfessor Klein is an Associate Professor of Systems Biology at Harvard Medical School. He obtained his PhD in physics with Prof. Ben Simons (Cambridge University)\, and a postdoc in experimental systems biology with Prof. Marc Kirschner (Harvard Medical School). Dr. Klein studies how cells make fate choices in developing and adult tissues. He pioneered droplet microfluidics for single-cell RNA-Seq\, computational methods for analyzing single-cell genomics data\, and methods for quantitative clonal analysis. He focuses on the early embryo\, epithelial tissues and the hematopoietic system as model systems. His work includes the discovery of a cell type in the airway epithelium (the pulmonary ionocyte)\, defining the identity of red blood cell progenitors\, and establishing the transcriptional dynamics of early vertebrate development at single cell resolution. In 2018\, Dr. Klein’s work mapping embryonic development in vertebrates was recognized by the AAAS “Breakthrough of the Year\,” and in 2020 he received the Dr. Susan Lim Award for Outstanding Young Investigator from the International Society for Stem Cell Research (ISSCR). \n Learn more about Allon Klein’s lab
URL:https://mbd.ccrm.ca/event/global-speaker-series-allon-klein-phd-harvard-medical-school/
LOCATION:Virtual
CATEGORIES:Global Speaker Series
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20201215T120000
DTEND;TZID=America/Toronto:20201215T130000
DTSTAMP:20260405T205446
CREATED:20201026T180404Z
LAST-MODIFIED:20210108T203414Z
UID:10245-1608033600-1608037200@mbd.ccrm.ca
SUMMARY:Adipose Biology Seminar Series
DESCRIPTION:The adipose tissue is an organ widely distributed throughout the body\, and it is involved in a large variety of medical conditions and metabolic disorders. In recent years\, there has been a growing interest in adipose tissue biology research\, both internationally and locally\, in different departments and institutes. This seminar series serves to facilitate discussion and foster collaborations between PIs and trainees with an interest in adipose tissue research in the Toronto region and beyond. The Adipose Biology Seminar Series is an online monthly meeting in which PIs and trainees will present and discuss novel data pertinent to adipose tissue biology. We aim to host speakers from diverse research foci such as obesity\, diabetes\, cancer and trauma to provide an opportunity to learn about exciting new developments in the field and build connections within a local network. If you are interested in showcasing your work and ideas to the adipose research community\, please contact the meeting organizers. \nTo join this group\, please send an email.
URL:https://mbd.ccrm.ca/event/adipose-biology-seminar-series/
LOCATION:Virtual
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20201207T083000
DTEND;TZID=America/Toronto:20201208T143000
DTSTAMP:20260405T205446
CREATED:20200731T170114Z
LAST-MODIFIED:20210108T203916Z
UID:8684-1607329800-1607437800@mbd.ccrm.ca
SUMMARY:Medicine by Design 5th Annual Symposium
DESCRIPTION:Event Details\nDay 1: Monday\, December 7 — 8:30 a.m. to 2:00 p.m.\nDay 2: Tuesday\, December 8 — 10:30 a.m. to 2:30 p.m.\n*Medicine by Design’s 5th Annual Symposium is a two-day event. Participants will automatically be registered for all sessions. \nMedicine by Design’s 5th Annual Symposium will bring together principal investigators and trainees from across the University of Toronto and its affiliated hospitals\, members of our Scientific Advisory Board\, representatives from our ecosystem partners across industry\, the investment community\, government and the not-for-profit sector\, and international collaborators to advance our research toward impact. \nThe theme of this year’s virtual symposium is Better Science through Convergence. Through talks by invited speakers from across North America and Medicine by Design principal investigators\, we will highlight how collaboration and convergence across research disciplines are accelerating regenerative medicine discoveries and translation. We will also hold a virtual poster session featuring the research of select trainees working on Medicine by Design-funded projects. \nInvited Speakers\n \nGeneral Registration\nGeneral registration is now closed. If you have any questions\, please email info.mbd@utoronto.ca. \nVirtual Poster Session\nThe symposium will feature a virtual poster session to highlight the research taking place in Medicine by Design-funded labs. All attendees are encouraged to browse the posters\, which will be displayed on the virtual platform\, at any time during the symposium. Trainees whose posters are featured in the session will be available to discuss their work on December 7\, from 12:15 p.m. to 2 p.m. \nThe submission period for poster abstracts is now closed. If you have any questions\, please email info.mbd@utoronto.ca. \nAgenda\n Download Agenda
URL:https://mbd.ccrm.ca/event/5th-annual-medicine-by-design-symposium/
LOCATION:Virtual
CATEGORIES:Symposium
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20201130T140000
DTEND;TZID=America/Toronto:20201130T150000
DTSTAMP:20260405T205446
CREATED:20201027T161807Z
LAST-MODIFIED:20201027T161807Z
UID:10266-1606744800-1606748400@mbd.ccrm.ca
SUMMARY:Myogenesis Discussion Group
DESCRIPTION:Please send an email to find out more about the myogenesis discussion group. \nAbout the Myogenesis Discussion Group\nThe study of myology (skeletal\, smooth and cardiac muscle structure\, function and development) has wide-ranging importance in the field of regenerative medicine. Skeletal muscle is the most abundant tissue in the human body and cardiac muscle is required to circulate blood throughout it. Furthermore\, smooth muscle is present in the walls of hollow organs and the vasculature system\, making these tissues critical for normal physiological function. The goal of this discussion group is to explore models of development\, disease and regeneration in muscle tissues\, as well as potential therapeutic approaches. Within this\, we aim to discuss novel techniques to quantitatively measure all aspects of myology and the challenges associated with developing representative models for these complex tissues.
URL:https://mbd.ccrm.ca/event/myogenesis-discussion-group-3/
LOCATION:Virtual
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20201117T120000
DTEND;TZID=America/Toronto:20201117T130000
DTSTAMP:20260405T205446
CREATED:20200204T180647Z
LAST-MODIFIED:20201103T223731Z
UID:7803-1605614400-1605618000@mbd.ccrm.ca
SUMMARY:Global Speaker Series: Fei Chen\, PhD - Broad Institute of MIT and Harvard
DESCRIPTION:The Medicine by Design Global Speaker Series invites established and emerging international leaders in regenerative medicine to engage with our extraordinary community of researchers and clinicians. \nMedicine by Design\, in partnership with the McEwen Stem Cell Institute\, is pleased to welcome Fei Chen\, PhD\, a Schmidt Fellow at the Broad Institute of Harvard University and the Massachusetts Institute of Technology. \nThe title of this talk will be\, “Next generation tools for spatial and temporal genomics” \nClick HERE to register for this virtual event. \n  \n \nMore About Fei Chen: \nFei Chen is currently a core faculty member at the Broad Institute of MIT and Harvard\, and assistant professor at Harvard Stem Cell and Regenerative Biology. He obtained his PhD in biological engineering from the Massachusetts Institute of Technology in 2016. Fei was a Schmidt Fellow at the Broad Institute of MIT and Harvard from 2017-2020. Fei was an Axline scholar at the California Institute of Technology and graduated with a bachelor’s degree in Electrical Engineering in 2011. At the Broad Institute of MIT and Harvard\, his lab sets out pioneer novel tools at the intersection of genomics and microscopy to bridge single-cell genomics with space and time to enable discoveries of where cell types are localized within intact tissues\, when relevant transcriptional modules are active. His awards include the National Institutes of Health Director’s Early Independence Award and the Allen Distinguished Investigator Award.
URL:https://mbd.ccrm.ca/event/global-speaker-series-fei-chen-phd-broad-institute/
LOCATION:Virtual
CATEGORIES:Global Speaker Series
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20201112T120000
DTEND;TZID=America/Toronto:20201112T133000
DTSTAMP:20260405T205446
CREATED:20201102T192657Z
LAST-MODIFIED:20201229T204130Z
UID:10392-1605182400-1605187800@mbd.ccrm.ca
SUMMARY:Medicine by Design Healthy and Inclusive Labs: Manu Platt\, PhD\, and Anita Balakrishna\, LLB
DESCRIPTION:Theme of this talk: Bridging the racial divide in society and academia\nMedicine by Design Healthy and Inclusive Labs Committee invites you to join us for this interactive discussion with Associate Professor Manu Platt\, PhD\, Wallace H. Coulter Department of Biomedical Engineering at the Georgia Institute of Technology\, and Emory University and Anita Balakrishna\, LLB\, Director\, Equity\, Diversity & Inclusion\, Temerty Faculty of Medicine\, U of T about bridging the racial divide in society and academia. \nThis is the first in a series of events offered by Medicine by Design’s Healthy and Inclusive Labs Committee. These events will create opportunities for the Medicine by Design Community to engage in conversations about the importance of equity\, diversity and inclusion in innovation; systemic racism; unconscious bias; barriers to inclusion in the academy; and much more. The goal is to spark change in our labs\, our community\, and in STEM more broadly. \nClick HERE to register for this virtual event. \n  \n \nManu Platt\nManu Platt received his BS in biology from Morehouse College in 2001 and his PhD from the Georgia Tech and Emory joint program in biomedical engineering in 2006. He finished his post-doctoral training at MIT in orthopedic tissue engineering and systems biology prior to returning to Georgia Tech and Emory’s Joint Department of Biomedical Engineering in 2009\, where he has since been promoted and tenured. His research centers on proteolytic mechanisms of tissue remodeling during disease progression using both experimental and computational approaches. \nIntegrated with his research program is his mentoring goal of changing the look of the next generation of scientists and engineers to include all colours\, genders\, and backgrounds. Aligned with that goal\, Dr. Platt\, along with Bob Nerem\, co-founded and co-directs Project ENGAGES (Engaging the Next Generation At Georgia Tech in Engineering and Science)\, a program paying African-American high school students from Atlanta Public Schools to be researchers in Georgia Tech labs since 2013. \n  \n \nAnita Balakrishna\nAnita Balakrishna is currently serving as the Director\, Equity\, Diversity and Inclusion at the University of Toronto Faculty of Medicine. Anita is a lawyer and educator with a human rights background. She has focused on a social justice based practice\, providing legal advocacy\, education\, and law reform activities alongside low-income and other underserved communities through her work at the Human Rights Legal Support Centre\, the South Asian Legal Clinic of Ontario and the Rexdale Community Legal Clinic. \nEvent Agenda\n\n12:00pm – 12:05pm Welcoming Remarks  – Molly Shoichet\n12:05pm – 12:15pm Introduction Presentation – Anita Balakrishna\n12:15pm – 1:00pm Presentation – Manu Platt\n1:00pm – 1:25pm Panel Discussion – Manu Platt and Anita Balakrishna (Moderated by Molly Shoichet)\n1:25pm – 1:30pm Closing Remarks – Molly Shoichet
URL:https://mbd.ccrm.ca/event/bridging-the-racial-divide/
LOCATION:Virtual
CATEGORIES:Other Events
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20201027T120000
DTEND;TZID=America/Toronto:20201027T130000
DTSTAMP:20260405T205446
CREATED:20201026T180617Z
LAST-MODIFIED:20201026T180617Z
UID:10241-1603800000-1603803600@mbd.ccrm.ca
SUMMARY:Adipose Biology Seminar Series
DESCRIPTION:The adipose tissue is an organ widely distributed throughout the body\, and it is involved in a large variety of medical conditions and metabolic disorders. In recent years\, there has been a growing interest in adipose tissue biology research\, both internationally and locally\, in different departments and institutes. This seminar series serves to facilitate discussion and foster collaborations between PIs and trainees with an interest in adipose tissue research in the Toronto region and beyond. The Adipose Biology Seminar Series is an online monthly meeting in which PIs and trainees will present and discuss novel data pertinent to adipose tissue biology. We aim to host speakers from diverse research foci such as obesity\, diabetes\, cancer and trauma to provide an opportunity to learn about exciting new developments in the field and build connections within a local network. If you are interested in showcasing your work and ideas to the adipose research community\, please contact the meeting organizers. \nTo join this group\, please send an email.
URL:https://mbd.ccrm.ca/event/adipose-biology-seminar-series-3/
LOCATION:Virtual
CATEGORIES:Discussion Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20201020T120000
DTEND;TZID=America/Toronto:20201020T130000
DTSTAMP:20260405T205446
CREATED:20191127T181319Z
LAST-MODIFIED:20200918T210631Z
UID:7553-1603195200-1603198800@mbd.ccrm.ca
SUMMARY:Global Speaker Series: Bryan Dickinson\, PhD - University of Chicago
DESCRIPTION:The Medicine by Design Global Speaker Series invites established and emerging international leaders in regenerative medicine to engage with our extraordinary community of researchers and clinicians. \nMedicine by Design\, in partnership with the McEwen Stem Cell Institute\, is pleased to welcome Bryan Dickinson\, PhD\, associate professor of chemistry at the University of Chicago. \nThe title of this talk will be\, “Synthetic biology approaches to study and exploit RNA regulation” \nClick HERE to register for this virtual event. \n \nMore About Bryan Dickinson: \nBryan Dickinson earned his BS in biochemistry from the University of Maryland\, College Park and his PhD in chemistry from the University of California at Berkeley for work performed with Professor Christopher Chang. His graduate work focused on the synthesis and application of small molecule fluorescent probes for the detection of hydrogen peroxide in living systems. Then\, as a Jane Coffin Childs Memorial post-doctoral fellow with Professor David Liu at Harvard University\, he developed new methods to rapidly evolve proteins to perform novel functions. Bryan joined the faculty at the University of Chicago in the Department of Chemistry in the summer of 2014 and is a member of the University of Chicago Comprehensive Cancer Center. He was promoted to Associate Professor in 2019.
URL:https://mbd.ccrm.ca/event/global-speaker-series-bryan-dickinson-october-2020/
LOCATION:Virtual
CATEGORIES:Global Speaker Series
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20201007T130000
DTEND;TZID=America/Toronto:20201007T140000
DTSTAMP:20260405T205446
CREATED:20200918T205929Z
LAST-MODIFIED:20201203T035737Z
UID:9428-1602075600-1602079200@mbd.ccrm.ca
SUMMARY:Career Speaker Series - Rahul Sarugaser\, PhD\, MBA
DESCRIPTION:Featuring University of Toronto alumnus Rahul Sarugaser\, PhD\, MBA\, Managing Director\, Equity Research Analyst\, Medical Technologies at Raymond James \n \nBiography: \nRahul holds a PhD and MASc in biomedical engineering from the University of Toronto\, and an MBA from the University of Oxford. Prior to joining Raymond James Ltd.\, Rahul’s roles included Equity Research Analyst\, Healthcare & Biotechnology with Paradigm Capital\, Director of Business Development at the Centre for Commercialization of Regenerative Medicine (CCRM)\, Investment Manager with the Toronto based MaRS Investment Accelerator Fund\, and Strategic Marketing Analyst with GE Healthcare’s headquarters in the U.K. \nAbout the series \nThe Medicine by Design Career Speaker Series features speakers who earned a graduate degree in regenerative medicine-related fields and have gone on to build interesting\, and often unique\, careers. They will speak about the challenges and opportunities of navigating a career in this emerging industry without a road map. These webinars are for graduate students\, post-doctoral fellows and research associates in regenerative medicine-related fields. \n 
URL:https://mbd.ccrm.ca/event/career-speaker-series-rahul-sarugaser/
LOCATION:Virtual
CATEGORIES:Career Speaker Series
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200915T120000
DTEND;TZID=America/Toronto:20200915T130000
DTSTAMP:20260405T205446
CREATED:20200204T180324Z
LAST-MODIFIED:20200820T135938Z
UID:7801-1600171200-1600174800@mbd.ccrm.ca
SUMMARY:Global Speaker Series: James J. Collins\, PhD - Massachusetts Institute of Technology (MIT)
DESCRIPTION:The Medicine by Design Global Speaker Series invites established and emerging international leaders in regenerative medicine to engage with our extraordinary community of researchers and clinicians. \nMedicine by Design\, in partnership with the McEwen Stem Cell Institute\, is pleased to welcome James J. Collins\, PhD\, Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT\, as well as a Member of the Harvard-MIT Health Sciences & Technology Faculty. \nThe title of this talk will be\, “Harnessing synthetic biology and AI to address the COVID-19 pandemic” \nClick HERE to register for this Virtual Event. \n  \n \nMore About Professor James J. Collins: \nProfessor Collins is also a Core Founding Faculty member of the Wyss Institute for Biologically Inspired Engineering at Harvard University\, an Institute Member of the Broad Institute of MIT and Harvard and a member of the Medicine by Design’s Scientific Advisory Board. He is one of the founders of the field of synthetic biology\, and his research group is currently focused on using synthetic biology to create next-generation diagnostics and therapeutics. Professor Collins’ patented technologies have been licensed by over 25 biotech\, pharma and medical devices companies\, and he has helped to launch a number of companies\, including Synlogic and Sherlock Biosciences. He has received numerous awards and honors\, including a Rhodes Scholarship and a MacArthur “Genius” Award\, and he is an elected member of all three national academies – the National Academy of Sciences\, the National Academy of Engineering\, and the National Academy of Medicine.
URL:https://mbd.ccrm.ca/event/global-speaker-series-september-2020/
LOCATION:Online
CATEGORIES:Global Speaker Series
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200914T120000
DTEND;TZID=America/Toronto:20200914T130000
DTSTAMP:20260405T205446
CREATED:20201006T122246Z
LAST-MODIFIED:20220818T141118Z
UID:9743-1600084800-1600088400@mbd.ccrm.ca
SUMMARY:Career Speaker Series - Nika Shakiba\, PhD
DESCRIPTION:Featuring University of Toronto graduate Nika Shakiba\, PhD\, Assistant Professor at the University of British Columbia Register at this link.  \nBiography:\nNika Shakiba is an Assistant Professor at the University of British Columbia. Her group applies systems and synthetic biology approaches to reverse and forward engineer the competitive interactions between stem cells. Nika completed her postdoctoral training in Drs. Ron Weiss and Domitilla Del Vecchio’s labs in the Department of Biological Engineering at Massachusetts Institute of Technology and her doctoral training in Dr. Peter Zandstra’s Stem Cell Bioengineering lab\, then at the University of Toronto. Outside of the lab\, Nika has a passion for outreach and mentorship and is co-founder of the Advice to a Scientist initiative. \nLearn more about Nika’s lab\nAbout the series\nThe Career Speaker Series will feature speakers who earned a graduate degree in regenerative medicine-related fields and have gone on to build interesting\, and often unique\, careers. They will speak about the challenges and opportunities of navigating a career in this emerging industry without a road map. These webinars are for graduate students\, post-doctoral fellows and research associates in regenerative medicine-related fields.  
URL:https://mbd.ccrm.ca/event/career-speaker-series-nika-shakiba-phd/
LOCATION:Virtual
CATEGORIES:Career Speaker Series
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200730T103000
DTEND;TZID=America/Toronto:20200730T120000
DTSTAMP:20260405T205446
CREATED:20200715T182920Z
LAST-MODIFIED:20200724T175518Z
UID:8631-1596105000-1596110400@mbd.ccrm.ca
SUMMARY:Panel Discussion: Translating Research to Impact – Leveraging our Ecosystem
DESCRIPTION:Please register using this form.\n\nDiscussion Moderator: Allison Brown\, Medicine by Design.\n\nThis panel discussion with regenerative medicine leaders from across Canada will discuss the following: \n\nThe journey of an academic serial entrepreneur\nGetting started on a path towards commercialization\nInnovative models for forming and scaling new ventures\nWhat to expect working for a start-up\n\n\nPanelist: Shana Kelley\, University Professor\, Leslie Dan Faculty of Pharmacy\, University of Toronto\nShana Kelley is a University Professor at the University of Toronto and a member of the departments of Chemistry\, Biochemistry\, Pharmaceutical Sciences and Biomedical Engineering. The Kelley research group works in a variety of areas spanning biophysical/bioanalytical chemistry\, chemical biology and nanotechnology\, and has pioneered new methods for tracking molecular and cellular analytes with unprecedented sensitivity. Shana’s work has been recognized with a variety of distinctions\, including being named one of “Canada’s Top 40 under 40” and a NSERC E.W.R. Steacie Fellow\, and being awarded the 2011 Steacie Prize\, and the 2016 NSERC Brockhouse Prize. She has also been recognized with the ACS Inorganic Nanoscience Award\, the Pittsburgh Conference Achievement Award\, an Alfred P. Sloan Research Fellowship\, a Camille Dreyfus Teacher-Scholar award\, a NSF CAREER Award\, and a Dreyfus New Faculty Award\, and was also named a “Top 100 Innovator” by MIT’s Technology Review. Shana is an inventor on over 50 patents issued worldwide. She is a founder of three molecular diagnostics companies\, GeneOhm Sciences (acquired by Becton Dickinson in 2005)\, Xagenic Inc. (acquired by General Atomics in 2017)\, and Cellular Analytics. Shana is the Director of PRiME\, an initiative focused on next-generation precision medicine that unites physical scientists\, engineers\, biologists and clinicians developing new therapeutics and diagnostics. Shana serves as a board director for the Fight Against Cancer Innovation Trust (FACIT) and the Canadian Academy of Health Sciences. She is an associate editor for ACS Sensors\, and an editorial advisory board member for the Journal of the American Chemical Society\, Nano Letters\, and ACS Nano.5 \nPanelist: Mara Lederman\, Professor of Strategic Management\, Rotman School of Management\, and Academic Lead\, Creative Destruction Lab Partners Program and CDL-Toronto Site Lead\nMara is a professor at the Rotman School of Management at the University of Toronto. She joined the faculty at the University of Toronto in 2003 after completing a PhD in economics at MIT. Mara does research in the areas of industrial organization and organizational economics. At a broad level\, she studies how companies compete for competitive advantage. She is best known for her research on loyalty programs and organizational design and has been invited to present her work on these topics at a variety of institutions including Harvard Business School\, the University of Chicago’s Booth School of Business\, and Northwestern’s Kellogg School of Management. Mara is also the site lead for the Toronto site of the Creative Destruction Lab (CDL). The CDL is a not-for-profit program running on five university campuses across Canada and at Oxford University in the UK. The program helps deep-science based start-ups transform into massively scalable and financeable businesses. As site lead for CDL-Toronto\, she oversees key substantive components of CDL-Toronto’s sessions and operations\, consults on strategic elements of the CDL model\, leads faculty engagement and manages key external stakeholder relationships. She also serves as the academic lead for CDL-Global’s Partners Program\, a nine-month offering that teaches organizations about the economic implications of emerging technologies through educational modules that are integrated with partners’ participation in the CDL program. \nPanelist: Tamer Mohamed\, President and CEO\, Aspect Biosystems\nA bioengineer\, inventor\, and entrepreneur\, Tamer currently serves as President and CEO of Aspect Biosystems. The company is tackling some of the biggest challenges in medicine by enabling the 3D printing of living human tissues. Tamer co-founded Aspect in 2013 and has played a leading role in overall corporate\, business\, and technology development. As a leader and visionary in the field of regenerative medicine and 3D printing\, he has been invited to speak on this topic at venues ranging from TEDx to industry\, scientific and executive conferences. He was awarded with BC’s Top 30 under 30 award for demonstrating excellence in business\, judgement\, leadership\, and community contribution. Tamer serves on the Board of Directors for ACETECH\, a non-profit training and mentoring organization for CEOs of technology and life sciences companies\, and on the Board of Directors for The Stem Cell Network\, an organization focused on building Canada’s stem cell and regenerative medicine research sector. \nPanelist: Michael Scott\, Senior Vice-President\, Product Development\, BlueRock Therapeutics\nMichael Scott joined BlueRock in 2017 to oversee the company’s product realization processes and Toronto operations. In this role\, he is a key part of the team focused on cell therapy product development including cell processes\, assay development and delivery devices for dopaminergic neurons to treat Parkinson’s disease and cardiomyocytes to treat congestive heart failure. Prior to joining BlueRock\, Dr. Scott served as Chief Development Officer and Vice President of Research and Development at ViaCyte\, a clinical-stage biotechnology company focused on the treatment of type I diabetes with a stem cell-based therapy product. He received a PhD in medical biophysics from the University of Western Ontario\, and masters and bachelor’s degrees in civil engineering from the University of Waterloo.
URL:https://mbd.ccrm.ca/event/panel-discussion-translating-research-to-impact-leveraging-our-ecosystem/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200624T130000
DTEND;TZID=America/Toronto:20200624T140000
DTSTAMP:20260405T205446
CREATED:20200417T164859Z
LAST-MODIFIED:20200610T151625Z
UID:8085-1593003600-1593007200@mbd.ccrm.ca
SUMMARY:Researcher Spotlight: Thomas Hurd\, PhD
DESCRIPTION:Register at this link\n \nThis webinar will be an opportunity to hear from a Medicine by Design-funded investigator. This session will feature Thomas Hurd\, a Medicine by Design New Investigator\, and he will discuss his work on mitochondrial quality control in the Drosophila germline. \nThomas Hurd completed his undergraduate degree at the University of Toronto\, PhD at the University of Cambridge (UK) and post-doctoral training at New York University School of Medicine (USA). The central focus of his research is understanding how mitochondria influence stem cell function\, fate and differentiation. His research also focuses on how mitochondria are inherited from mother to offspring.
URL:https://mbd.ccrm.ca/event/new-investigator-series/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200618T103000
DTEND;TZID=America/Toronto:20200618T123000
DTSTAMP:20260405T205446
CREATED:20200602T142239Z
LAST-MODIFIED:20200612T200559Z
UID:8412-1592476200-1592483400@mbd.ccrm.ca
SUMMARY:Translation Talks
DESCRIPTION:Register for Translation Talks at this link. \nHow do you move innovative regenerative medicine discoveries out of the lab efficiently and effectively so patients benefit sooner? Medicine by Design is partnering with CCRM and Stem Cell Network to offer Translation Talks\, a series of seven weekly webinars for graduate students\, post-doctoral fellows and research/scientific associates that will provide an in-depth look at key concepts in the translation and commercialization of regenerative medicine. Experts in the field will deliver interactive talks on a range of topics including:  \n•	Introduction to Commercialization of Regenerative Medicine\n•	Economic Reimbursement and Technology Adoption\n•	Regulatory Affairs and Clinical Translation\n•	Intellectual Property\n•	Early-Stage Investment and Company Valuations\n•	Manufacturing\n•	Panel Discussion: Exploring the Toronto Regenerative Medicine Ecosystem \nThe series will start on Thursday\, June 18\, and run every Thursday until July 30. Each webinar will begin at 10:30 a.m. ET and will last for between 90 minutes and two hours\, depending on the week. As the topics covered will be cumulative\, participants are asked to commit to attending all seven webinars. A detailed agenda with topics and speakers will be distributed to registered participants in June.
URL:https://mbd.ccrm.ca/event/translation-talks-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200617T150000
DTEND;TZID=America/Toronto:20200617T160000
DTSTAMP:20260405T205446
CREATED:20200417T171809Z
LAST-MODIFIED:20200612T144126Z
UID:8096-1592406000-1592409600@mbd.ccrm.ca
SUMMARY:Career Speaker Series - Shreya Shukla
DESCRIPTION:Featuring University of Toronto alumnus Shreya Shukla\, Director\, Research\, Notch Therapeutics \n \nRegister at this link. \nShreya Shukla is a Co-Founder and Director of Research at Notch Therapeutics\, advancing universal iPSC-derived immune cell therapeutic programs from discovery-stage to scale-up. She leads the design and execution of process optimization projects and contributes to IP strategy related to novel platform developments. She also works closely with senior leadership to coordinate the ideation phase and planning of new programs and technologies in the Notch pipeline. Previously\, she worked at CCRM as a scientist/entrepreneur/co-inventor in a company incubation team focused on creating and launching Notch Therapeutics. She designed and executed proof-of-concept research studies demonstrating the value proposition of Notch’s Engineered Thymic Niche (ETN) manufacturing platform that catalyzed investment and industry partnerships. She also contributed to Notch’s business development via a breadth of activities spanning KOL outreach\, business operations\, pipeline development planning\, financial tracking\, pitch deck creation\, IP strategy\, investor diligence\, partner engagement\, start-up team recruitment etc. Shreya completed her Ph.D. in Biomedical Engineering from Dr. Peter Zandstra’s stem cell bioengineering laboratory at University of Toronto in Canada and her B.S. in Biomedical Engineering from Georgia Institute of Technology in USA. \n\nAbout the series\nTo what extent can we plan and design our careers? How much depends on our environment\, the choices we make\, the opportunities that present themselves\, the networks we build\, and the achievements and failures we experience along the way? The Career Speaker Series will feature speakers who earned a graduate degree and have built interesting careers in regenerative medicine. They will speak about the challenges and opportunities of navigating a career in this emerging industry without a road map. These webinars are for graduate students\, post-doctoral fellows and research associates in regenerative medicine-related fields. \n 
URL:https://mbd.ccrm.ca/event/career-speaker-series-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200616T120000
DTEND;TZID=America/Toronto:20200616T130000
DTSTAMP:20260405T205446
CREATED:20191127T180959Z
LAST-MODIFIED:20201203T220705Z
UID:7551-1592308800-1592312400@mbd.ccrm.ca
SUMMARY:Global Speaker Series: Ulrich Steidl\, MD\, PhD - Albert Einstein College of Medicine
DESCRIPTION:Medicine by Design\, in partnership with the McEwen Stem Cell Institute\, is pleased to welcome Ulrich Steidl\, MD\, PhD\, professor of cell biology and medicine at the Albert Einstein College of Medicine. The title of this talk will be\, “Stem cell heterogeneity and transcription state dynamics in normal and malignant hematopoiesis.” \n  \n \nAbout Ulrich Steidl\nDr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research\, director of the Stem Cell Isolation and Xenotransplantation Facility\, and a professor of cell biology and of medicine at Albert Einstein College of Medicine\, and associate chair for translational research in oncology at Montefiore Medical Centre. \nThe Medicine by Design Global Speaker Series invites established and emerging international leaders in regenerative medicine to engage with our extraordinary community of researchers and clinicians.
URL:https://mbd.ccrm.ca/event/global-speaker-series-ulrich-steidl-june-2020/
LOCATION:Online
CATEGORIES:Global Speaker Series
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200527T150000
DTEND;TZID=America/Toronto:20200527T160000
DTSTAMP:20260405T205446
CREATED:20200417T170936Z
LAST-MODIFIED:20200519T170735Z
UID:8094-1590591600-1590595200@mbd.ccrm.ca
SUMMARY:Career Speaker Series - Ali Khademhosseini
DESCRIPTION:Featuring University of Toronto alumnus Ali Khademhosseini\, CEO and Founding Director\, Terasaki Institute for Biomedical Innovation\nRegister at this link. \n\n\nAli Khademhosseini is the CEO and Founding Director of the Terasaki Institute for Biomedical Innovation. He is also a Researcher for Amazon Web Services (AWS) Inc. Previously\, he was a Professor of Bioengineering\, Chemical Engineering and Radiology at the University of California-Los Angeles (UCLA). He joined UCLA as the Levi Knight Chair starting Nov. 2017 from Harvard University where he was a Professor at the Harvard Medical School (HMS) and faculty at the Harvard-MIT’s Division of Health Sciences and Technology (HST)\, Brigham and Women’s Hospital (BWH) and as well as associate faculty at the Wyss Institute for Biologically Inspired Engineering. At Harvard University\, he directed the Biomaterials Innovation Research Center (BIRC) a leading initiative in making engineered biomedical materials. He is recognized as a leader in combining micro and nano-engineering approaches with advanced biomaterials for regenerative medicine applications. He is a recipient of the Presidential Early Career Award for Scientists and Engineers\, the highest honor given by the US government for early career investigators. In 2011\, he received the Pioneers of Miniaturization Prize from the Royal Society of Chemistry (RSC) for his contribution to microscale tissue engineering and microfluidics. In 2016\, he received the Sr. Scientist Award of Tissue Engineering and Regenerative Medicine Society -Americas Chapter (TERMIS-AM)\, and in 2017 he received the Clemson Award of the Society for Biomaterials. He is a fellow of the American Institute of Medical and Biological Engineering (AIMBE)\, Biomedical Engineering Society (BMES)\, Royal Society of Chemistry (RSC)\, Biomaterials Science and Engineering (FBSE)\, Materials Research Society (MRS)\, NANOSMAT Society\, and American Association for the Advancement of Science (AAAS). He is also the recipient of the Mustafa Prize ($500\,000 prize) as well as a member of the International Academy of Medical and Biological Engineering\, Royal Society of Canada and Canadian Academy of Engineering. Currently he serves on the editorial board of numerous leading journals as well as an Associate Editor for ACS Nano. He received his Ph.D. in bioengineering from MIT (2005)\, and MASc (2001) and BASc (1999) degrees from University of Toronto both in chemical engineering. \n  \n\nAbout the series\nTo what extent can we plan and design our careers? How much depends on our environment\, the choices we make\, the opportunities that present themselves\, the networks we build\, and the achievements and failures we experience along the way? The Career Speaker Series will feature speakers who earned a graduate degree and have built interesting careers in regenerative medicine. They will speak about the challenges and opportunities of navigating a career in this emerging industry without a road map. These webinars are for graduate students\, post-doctoral fellows and research associates in regenerative medicine-related fields.
URL:https://mbd.ccrm.ca/event/career-speaker-series-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200525T140000
DTEND;TZID=America/Toronto:20200525T150000
DTSTAMP:20260405T205446
CREATED:20200424T164103Z
LAST-MODIFIED:20200424T174726Z
UID:8195-1590415200-1590418800@mbd.ccrm.ca
SUMMARY:Myogenesis Discussion Group - virtual seminar
DESCRIPTION:Please contact Louise Moyle at louise.moyle@utoronto.ca to find out how to join the Myogenesis Discussion Group – virtual serminar \nAbout the Myogenesis Discussion Group\nThe study of myology (skeletal\, smooth and cardiac muscle structure\, function and development) has wide-ranging importance in the field of regenerative medicine. Skeletal muscle is the most abundant tissue in the human body and cardiac muscle is required to circulate blood throughout it. Furthermore\, smooth muscle is present in the walls of hollow organs and the vasculature system\, making these tissues critical for normal physiological function. The goal of this discussion group is to explore models of development\, disease and regeneration in muscle tissues\, as well as potential therapeutic approaches. Within this\, we aim to discuss novel techniques to quantitatively measure all aspects of myology and the challenges associated with developing representative models for these complex tissues.
URL:https://mbd.ccrm.ca/event/myogenesis-discussion-group-virtual-seminar/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200513T150000
DTEND;TZID=America/Toronto:20200513T160000
DTSTAMP:20260405T205446
CREATED:20200417T170359Z
LAST-MODIFIED:20200506T165434Z
UID:8089-1589382000-1589385600@mbd.ccrm.ca
SUMMARY:Career Speaker Series - Matthew Hildebrandt
DESCRIPTION:Register at this link. \nFeaturing University of Toronto alumnus Matthew Hildebrandt\, PhD\, Product Manager\, STEMCELL Technologies \n \nMatthew Hildebrandt\, PhD\, joined STEMCELL Technologies in 2019 as an Associate Product Manager. STEMCELL Technologies is a global biotechnology company headquartered in Vancouver producing more than 2\,500 specialized media and cell separation products to support life science research. Dr. Hildebrandt’s academic career was focused around fundamental developmental and RNA biology which started with his PhD work in oncology at the University of Alberta in Edmonton and then continued with a post-doctoral fellowship with Dr. James Ellis at The Hospital for Sick Children in the Department of Developmental and Stem Cell Biology. Here he learned the benefits of human pluripotent stem cells as a model system and collaborated with several groups across Toronto to develop a resource of control human induced pluripotent stem cell lines. He now uses his experience in academia to support the development\, commercialization and maintenance of media products that support researchers using pluripotent stem cells.    \n\nAbout the series\nTo what extent can we plan and design our careers? How much depends on our environment\, the choices we make\, the opportunities that present themselves\, the networks we build\, and the achievements and failures we experience along the way? The Career Speaker Series will feature speakers who earned a graduate degree and have built interesting careers in regenerative medicine. They will speak about the challenges and opportunities of navigating a career in this emerging industry without a road map. These webinars are for graduate students\, post-doctoral fellows and research associates in regenerative medicine-related fields. \n 
URL:https://mbd.ccrm.ca/event/career-speaker-series/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200507T130000
DTEND;TZID=America/Toronto:20200507T140000
DTSTAMP:20260405T205446
CREATED:20200417T172133Z
LAST-MODIFIED:20200504T143410Z
UID:8098-1588856400-1588860000@mbd.ccrm.ca
SUMMARY:Introduction to Single Cell and Spatial Technologies webinar
DESCRIPTION:In this webinar\, Adriana Suarez from 10x Genomics will discuss the following:\n-Introduction to single cell and spatial technologies (with a focus on 10x Genomics).\n-Overview of experimental workflows for single cell and spatial analyses.\n-Utility of single cell and spatial technologies to advance stem cell biology\, developmental biology and regenerative medicine with examples on heart development\, lung atlas\, immunotherapy\, induced pluripotency and more. \nThis webinar is for investigators\, research/scientific associates\, trainees and lab technicians at the University of Toronto and its affiliated hospitals. Registration is required. The session will be offered via Zoom webinar. \nAbout single cell and spatial technologies\nThe vast complexities of biology require approaches to build a complete picture\, starting from single cells to tissues and beyond. Single cell and spatial technologies enable researchers to resolve highly complex biological systems\, while bringing into focus the details that matter most. \n\nRegistration for this webinar is now full. Thank you for your interest.
URL:https://mbd.ccrm.ca/event/introduction-to-single-cell-and-spatial-technologies-webinar/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200421T153000
DTEND;TZID=America/Toronto:20200421T163000
DTSTAMP:20260405T205446
CREATED:20200414T153106Z
LAST-MODIFIED:20200424T145838Z
UID:8079-1587483000-1587486600@mbd.ccrm.ca
SUMMARY:Virtual coffee breaks for trainees in the Medicine by Design community
DESCRIPTION:You are invited to join other trainees from the Medicine by Design community for sharing\, support and discussion at a virtual coffee break. \nBrew your favourite hot beverage and join the conversation.  The virtual coffee break will be an unstructured discussion that will allow participants to connect socially and professionally. \nEmail info.mbd@utoronto.ca to receive the link to the meeting.
URL:https://mbd.ccrm.ca/event/virtual-coffee-breaks-for-trainees-in-the-medicine-by-design-community-april-21/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200414T153000
DTEND;TZID=America/Toronto:20200414T163000
DTSTAMP:20260405T205446
CREATED:20200414T152704Z
LAST-MODIFIED:20200414T152704Z
UID:8076-1586878200-1586881800@mbd.ccrm.ca
SUMMARY:Virtual coffee breaks for trainees in the Medicine by Design community
DESCRIPTION:You are invited to join other trainees from the Medicine by Design community for sharing\, support and discussion at a virtual coffee break. \nBrew your favourite hot beverage and join the conversation.  The virtual coffee break will be an unstructured discussion that will allow participants to connect socially and professionally. \nEmail info.mbd@utoronto.ca to receive the link to the meeting.
URL:https://mbd.ccrm.ca/event/virtual-coffee-breaks-for-trainees-in-the-medicine-by-design-community/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200407T153000
DTEND;TZID=America/Toronto:20200407T163000
DTSTAMP:20260405T205446
CREATED:20200402T212701Z
LAST-MODIFIED:20200424T150134Z
UID:8047-1586273400-1586277000@mbd.ccrm.ca
SUMMARY:Virtual coffee break for trainees
DESCRIPTION:You are invited to join other trainees from the Medicine by Design community for sharing\, support and discussion at a virtual coffee break on Tuesday\, April 7\, at 3:30 p.m. to 4:30 p.m. \nBrew your favourite hot beverage and join the conversation. Hosted by Louise Moyle (Glibert lab)\, the virtual coffee break will be an unstructured discussion that will allow participants to connect socially and professionally. The topic of the discussion will be\, “Staying on top of the literature.” \nEmail info.mbd@utoronto.ca to receive the link to the meeting.
URL:https://mbd.ccrm.ca/event/virtual-coffee-break-for-trainees-april-7/
LOCATION:Online
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200331T140000
DTEND;TZID=America/Toronto:20200331T150000
DTSTAMP:20260405T205446
CREATED:20200327T155821Z
LAST-MODIFIED:20200424T150323Z
UID:8042-1585663200-1585666800@mbd.ccrm.ca
SUMMARY:Virtual coffee break for trainees
DESCRIPTION:Trainees in the Medicine by Design community are invited to attend virtual coffee breaks. \nVirtual coffee breaks are a chance to share ideas\, interact socially and discuss topics of interest. These unstructured chats are a way to engage with each other and continue scientific discussion\, even when many labs are closed as a result of the COVID-19 pandemic. \nThe chat on March 31 will be hosted by Maria Abou Chakra\, from the Bader lab\, and will be focused on the topic of Coping in Extraordinary Times. \nPlease email info.mbd@utoronto.ca to register to receive the meeting link.
URL:https://mbd.ccrm.ca/event/virtual-coffee-break-for-trainees-march-31/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200218T120000
DTEND;TZID=America/Toronto:20200218T130000
DTSTAMP:20260405T205446
CREATED:20191127T175612Z
LAST-MODIFIED:20200130T202459Z
UID:7543-1582027200-1582030800@mbd.ccrm.ca
SUMMARY:Global Speaker Series: Stuart Forbes\, MB\, ChB - University of Edinburgh
DESCRIPTION:The Medicine by Design Global Speaker Series invites established and emerging international leaders in regenerative medicine to engage with our extraordinary community of researchers and clinicians.  \nMedicine by Design\, in partnership with the McEwen Stem Cell Institute and the Ontario Institute for Regenerative Medicine\, is pleased to welcome Stuart Forbes\, MB\, ChB\, director of the Centre for Regenerative Medicine and professor of transplantation and regenerative medicine at the University of Edinburgh\, and consultant hepatologist at the Scottish Liver Transplant Unit. He will give a talk titled\, “Developing regenerative therapies for the damaged liver.” \n\nDownload event poster\nThe event will be livestreamed (link will be live shortly before event)\n\n  \nTalk Abstract\nThe normal liver regenerates well after injury but in severe or chronic damage the regeneration capability begins to fail and cellular senescence develops. We have studied human liver injury and regeneration to develop mouse models that develop epithelial senescence and model human disease. This has revealed plasticity between the biliary and hepatocyte population. The epithelial senescence also drives liver pathology such as fibrosis and can be targeted using small molecule approaches. \nBased upon our studies of liver injury and regeneration we have been developing cell therapies for liver disease including macrophage cell therapy for liver cirrhosis which is now in phase 2. \n  \nBiography\nStuart Forbes is Professor of Transplantation and Regenerative Medicine\, at the University of Edinburgh and the Scottish Liver Transplant Unit. His research focuses on how the chronically damaged liver regenerates and how these mechanisms process becomes deranged in liver and bile duct cancer. Prof. Forbes is Director of the MRC Centre for Regenerative Medicine\, University of Edinburgh which houses 230+ scientists and clinicians. He is Director of the UK wide UKRMP Hub for engineering and exploiting the stem cell niche which aims to exploit the biology of stem cell niches for translational benefit. Prof. Forbes is a consultant Hepatologist at the Scottish Liver Transplant Unit\, Royal Infirmary of Edinburgh and has clinical interests in liver failure\, cancer and transplantation and is running phase 1 and 2 trials of macrophage cell therapy for liver cirrhosis.
URL:https://mbd.ccrm.ca/event/global-speaker-series-stuart-forbes-february-2020/
LOCATION:Canada
CATEGORIES:Global Speaker Series
ORGANIZER;CN="Medicine by Design":MAILTO:info.mbd@utoronto.ca
END:VEVENT
END:VCALENDAR